A potential adverse effect of IL-6 inhibitors that requires lipid monitoring is?

• A. Elevated lipid levels
• B. GI perforation
• C. Anemia
• D. Headache

Answer: (A)

Blocking IL-6 signaling can cause elevations in blood lipids, so lipid levels need to be monitored when using IL-6 inhibitors. IL-6 influences hepatic lipid metabolism, and inhibiting it often leads to higher total cholesterol and LDL (and sometimes HDL) levels. Because of this, clinicians routinely obtain a fasting lipid panel before starting therapy and again after initiation, adjusting treatment (such as adding statins) if hyperlipidemia develops.

GI perforation, anemia, and headache are possible adverse effects of IL-6 inhibitors, but they are not the reason lipid monitoring is necessary. GI perforation is a serious risk, particularly in patients with diverticular disease; anemia relates to iron/metabolic effects; headache is a nonspecific symptom. The lipid changes specifically drive the need for lipid monitoring.